Trademark Search in Canada

T-REXBIO

View On IC.GC.CA

REGISTERED

on 21 Mar 2024

Last Applicant/ Owned by

TREX BIO INC.

681 Gateway Boulevard, 4th FloorSouth San Francisco, CA 94080

Serial Number

2048358 filed on 27^th Aug 2020

Registration Number

TMA1225783 registered on 21^st Mar 2024

Registration expiry Date

21^st Mar 2034

Correspondent Address

PERLEY-ROBERTSON, HILL & MCDOUGALL LLP

1400 - 340 ALBERT STREETOTTAWA

ONTARIO

K1R0A5

T-REXBIO

Trademark usage description

pharmaceutical preparations for the treatment of allergic diseases, antidrug immunogenicity, autoimmune diseases, cancer, cardiovascular diseases, chr Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of allergic diseases, antidrug immunogenicity, autoimmune diseases, cancer, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), diabetes, graft versus host disease (GvHD), hepatic cirrhosis, inflammatory bowel diseases and disorders, inflammatory connective tissue diseases and disorders, inflammatory muscle diseases and disorders, pulmonary fibrosis, renal fibrosis; Pharmaceutical preparations for use in tissue and organ transplantation; Anti-inflammatory preparations.

Classification kind code

Mark Details

Serial Number

2048358

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 21^st Mar 2024	Registration Pending
Submitted for opposition 42 on 3^rd Jan 2024	Advertised
Submitted for opposition 27 on 11^th Dec 2023	Approval Notice Sent
Submitted for opposition 26 on 11^th Dec 2023	Approved
Submitted for opposition 22 on 26^th Oct 2022	Search Recorded
Submitted for opposition 20 on 26^th Oct 2022	Examiner's First Report
Submitted for opposition 287 on 20^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 27^th Aug 2020	Filed
Submitted for opposition 1 on 27^th Aug 2020	Created
Submitted for opposition 31 on 27^th Aug 2020	Formalized